This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
September 4th-5th, 2024
San Diego Convention CenterSan Diego, USA

Meet the past speakers

RNA Leaders USA covers the whole ecosystem and has talks, discussions and attendees from all RNA disciplines.

2023 speakers


Heikki Lanckriet, CEO & CSO, 4Basebio
Amy Walker, VP of Research & Business Development, 4Basebio
Lykke Pedersen, Chief Pharma Officer, Abzu Aps
Eszter Békefi, Proposal Manager, AGC Biologics
Nate Spangler, CEO, Aldevron
Michelle Werner, CEO & Director, Alltrna
Vasant Jadhav, SVP, Head of RNAi Platform, Alnylam
Clara Assouline, Director, Business Development, Anima Biotech
Nicholas Marsh, Life Science Researcher, Arrakis Therapeutics
Frederic Legros, Executive Chairman & CEO, ARTHEx Biotech
Daniel Rosan, CEO, Ascidian Therapeutics
Annette Bak, Senior Director - Head of Advanced Drug Delivery, AstraZeneca
Sheri Ambriz, Senior Director - BD & Technical Solutio, Asymchem Inc
Vishal Doshi, Chairman, AUM Biosciences
Ariel Weinberger, CEO, Autonomous Therapeutics
Mike Flanagan, Co-Founder & CEO, Avidity Biosciences
Luis Brito, VP Delivery Platform, Beam Therapeutics
Yannick Fillon, Head of Oligonucleotide Process Chemistry, Biogen
Mark DeMario, CEO, BioNTech
Andreas Kuhn, SVP RNA Biochemistry & CMC Development, BioNTech
Gabriel Helmlinger, Associate Director, Scientific Strategy & Innovation, BIORCHESTRA
Josh Mandel-Brehm, CEO, Camp4 Therapeutics Corporation
Michael Rosenzweig, EVP, Capstan Therapeutics
Christopher Jewell, CSO, Cartesian Therapeutics
June Kim, Head of Targeted mRNA Delivery, CEPI (Coalition for Epidemic Preparedness and Innovation)
Javier Gimenez, Director, Certest Pharma
Shanthi Ganesh, Director, Discovery Research, Dicerna Pharmaceuticals
Iris Grossman, Principal, Eleven Therapeutics
Christalyn Rhodes, Associate VP- Genetic Medicine, External Partnerships & Collaborations, Eli Lilly
Malgorzata Gonciarz, CEO & Co-Founder, Eli Lilly
Tim Luker, VP Ventures, Eli Lilly
Akihiro Ko, CEO, Elixirgen Therapeutics
Dillon Flood, Co-Founder, Elsie Biotechnologies
Ryan Cross, Senior Science Correspondent, Endpoints News
Scott Laneman, Director of Innovation, Entegris
Leo Qian, Co-Founder & VP, Discovery Research, Entrada Therapeutics
Carsten Rudolph, CEO, Ethris
Patrick Thiaville, CTO, Exothera
Alex Philippidis, Senior Business Editor, Genetic Engineering & Biotechnology News
Kathleen Kean, Partner, Goodwin Procter
Matthew Hawryluk, Director of Product Management, Gritstone bio
Andrew Ferguson, VP Clinical Development, Gritstone bio
Leslie Williams, Co-Founder, Director, President & CEO, hC Bioscience
Nick Davis, mRNA Senior Scientist, HOVANA
David Slack, Senior Scientist, Impilo Therapeutics
Derek Hicks, CBO, Intellia Therapeutics
Eric Swayze, EVP, Research, Ionis Pharmaceuticals
Tamar Grossman, VP, Global Head of RNA, Gene Therapy & Delivery, Johnson & Johnson
Ram Aiyar, CEO, Korro Bio
Katerina Krumova, CFO, Laronde
Amy Espeseth, Head of Technical Operations, Laronde
Daniel Anderson, Professor, Massachusetts Institute of Technology
Daniel Quevedo, Senior Manager - Strategy & Business Development, METiS Therapeutics
Camden Cutright, Business Development Director, Micropore Technologies
Nagy Habib, Associate Director, Co-Founder, Chief Marketing Officer & Head of R&D, MiNA Therapeutics
Can Ozbal, CEO, Momentum Biotechnologies
Karin Kleinhans, Partner, MRLV
Jayesh Kulkarni, Business Developer Manager, NanoVation Therapeutics
Uli Stilz, Head of Bio Innovation Hub, Novo Nordisk
Mahesh Karande, VP Lilly Genetic Medicine, Omega Therapeutics
Thomas Barnes, CEO, Orna Therapeutics
Pallavi Lonkar, CTO, PepGen
Jing Zhu, VP of Nucleic Acid & Viral Vector Technology, Recipharm
Dominic Reynolds, SVP, Head of Drug Discovery, Remix Therapeutics
Sridhar Narayan, VP, Revir Therapeutics
Shraddha Sharma, Associate Director, Sanofi
Pierre Cote, Senior Director Strategic Partnerships & Innovation Management, mRNA CoE, Sanofi
Guillaume Pfefer, CEO & CSO, Senda Biosciences
Miroslav Gasparek, Co-Founder & CEO, Sensible Biotechnologies
Jimmy Weterings, VP of Research, Sirnaomics
Anna Perdrix Rosell, Founder & Co-CEO, Sixfold Bioscience
Huw Nash, Director, RNA Market Sectors Lead, Stoke Therapeutics
Dee Datta, CEO & Co-Founder, Switch Therapeutics
May Guo, Key Account Manager, Synthgene
Pedro Serrano, Senior Director & Head of Ribonucleic Acid & Protein Modulation, Takeda Pharmaceuticals
Matthias Hackl, CEO, TAmiRNA
David Davidson, VP Translational Neurology, Tessera Therapeutics
Angela Genge, Executive Director, Clinical Research Unit (CRU), The Montreal Neurological Institute
John Boyce, Co-Founder, Managing Director, TigerGene
Alicia Irurzun-Lafitte, Partner, UCB Ventures
Alex Kerr, Director of mRNA Platform, Unchained Labs
Aimee Edinger, Professor, University of California Irvine
Cesar Lopez-Camacho, Group Leader, University of Oxford
James Carroll, Managing Director, Wharton Alumni Angels
Dave Madge, VP Discovery Services, WuXi AppTec
Olivier Tytgat, Business Development Manager, Ziphius Vaccines